TALIS BIOMEDICAL CORP (TLIS) Stock News
NASDAQ:TLIS - Nasdaq - US87424L2079 - Common Stock - Currency: USD
TLIS Latest News, Press Relases and Analysis
TLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Talis Biomedical (NASDAQ:TLIS) just reported results for the second quarter of ...
TLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024
Talis Biomedical just reported results for the second quarter of 2024.
Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
Talis Biomedical stock is down on Wednesday as TLIS investors have concerns about board changes and a possible bankruptcy.
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Talis Biomedical (NASDAQ:TLIS) just reported results for the first quarter of 2...
TLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024
Talis Biomedical just reported results for the first quarter of 2024.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Talis Biomedical (NASDAQ:TLIS) just reported results for the fourth quarter of ...
TLIS Stock Earnings: Talis Biomedical Reported Results for Q4 2023
Talis Biomedical just reported results for the fourth quarter of 2023.
Talis reviewing strategic alternatives, stock rallies 35% (TLIS)
Talis Biomedical (TLIS) stock soared 35% after the company announced it was cutting its workforce by 90% and reviewing strategic alternatives. Read more here.
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
7 Small-Cap Stocks to Sell in August Before They Crash and Burn
There’s a time to buy and there’s a time to red flag small-cap stocks to avoid in August before they sink your portfolio.
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
Talis Biomedical regains compliance with Nasdaq's minimum bid price rule (NASDAQ:TLIS)
Diagnostic company Talis Biomedical (TLIS) said on Monday that it has regained compliance with Nasdaq's minimum bid price requirement of at least $1.00 per share.
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Talis Biomedical Announces 1-for-15 Reverse Stock Split
REDWOOD CITY, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health...
